Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL26599646

O=C(O)C(F)(F)F.Oc1nccc(N2CCNCC2)n1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 9/20 0.63
HRH3 Q9Y5N1 6/20 0.58
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
ADRB1 P08588 2/20 0.48
ADRB2 P07550 1/20 0.43
KDM4E B2RXH2 1/20 0.42
CYP3A4 P08684 1/20 0.42
HSD17B10 Q99714 1/20 0.42
RAD52 P43351 1/20 0.42
UBE2N P61088 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
IRAK4 Q9NWZ3 2/20 0.41
ADORA2A P29274 1/20 0.41
PRKCA P17252 1/20 0.41
PRKCQ Q04759 1/20 0.41
PRKCD Q05655 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3917783 0.88 HRH4 (0.61) HRH4HRH3CYP1A2CYP2C9ADRB1
SCHEMBL11042359 0.87 HRH3 (0.65) HRH4HRH3CYP1A2CYP2C9ADRB1
Trifluoroacetic Acid SCHEMBL5038086 0.85 HRH4 (0.58) HRH4HRH3CYP1A2CYP2C9ADRB1
Trifluoroacetic Acid SCHEMBL30618987 0.80 HRH4 (0.62) HRH4HRH3CYP1A2CYP2C9ADRB1
Trifluoroacetic Acid SCHEMBL26600738 0.80 HRH4 (0.62) HRH4HRH3CYP1A2CYP2C9ADRB1
Trifluoroacetic Acid SCHEMBL26600662 0.79 HRH4 (0.58) HRH4HRH3CYP1A2CYP2C9ADRB1
Trifluoroacetic Acid SCHEMBL26600666 0.77 ADRB1 (0.57) HRH4HRH3ADRB1ADRB2
SCHEMBL2850464 0.77 HRH3 (0.59) HRH4HRH3CYP1A2CYP2C9ADRB1
SCHEMBL26599637 0.76 HRH4 (0.52) HRH4HRH3CYP1A2CYP2C9ADRB1
Trifluoroacetic Acid SCHEMBL5038083 0.76 HRH4 (0.52) HRH4HRH3CYP1A2CYP2C9ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12454547-B2 Steroidal compositions and methods of treating lipogenic cancers Asteroid Therapeutics (US) 2025-10-28 US disclosed
US-20230340011-A1 STEROIDAL COMPOSITIONS AND METHODS OF TREATING LIPOGENIC CANCERS Asteroid Therapeutics 2023-10-26 US disclosed
WO-2023205801-A2 STEROIDAL COMPOSITIONS AND METHODS OF TREATING LIPOGENIC CANCERS Asteroid Therapeutics (US) 2023-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12454547-B2 Steroidal compositions and methods of treating lipogenic cancers SREBF1, SREBF2, NR1H3 HRH4 4558/4885HRH3 4494/4885CYP1A2 935/4885
US-20230340011-A1 STEROIDAL COMPOSITIONS AND METHODS OF TREATING LIPOGENIC CANCERS SREBF1, SREBF2, NR1H3 HRH4 4558/4885HRH3 4494/4885CYP1A2 935/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.